🧪 The “Aide au Développement Deeptech (ADD)” Grant is reserved for startups which develop highly technological innovations. So for BioMAdvanced... View Article
Author Archives for Adeline Chauvigné
BioMAdvanced Diagnostics received €900k in funding from Bpifrance
31 May 2025🧪 The “Aide au Développement Deeptech (ADD)” Grant is reserved for startups which develop highly technological innovations. So for BioMAdvanced... View Article
New member | YouCie
After an overview of the mechanisms of the pharmacy and the problems encountered by the pharmacist and the patient, YouCie... View Article
New member | YouCie
31 May 2025After an overview of the mechanisms of the pharmacy and the problems encountered by the pharmacist and the patient, YouCie... View Article
New member | Abcely
Abcely’s mission is to develop new innovative medical and pharmaceutical technologies in the field of the treatment of mucosal cancers,... View Article
New member | Abcely
31 May 2025Abcely’s mission is to develop new innovative medical and pharmaceutical technologies in the field of the treatment of mucosal cancers,... View Article
XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1 variant
In the context of a major resurgence of the COVID epidemic, the French biotech XENOTHERA has just carried out an... View Article
XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1 variant
31 May 2025In the context of a major resurgence of the COVID epidemic, the French biotech XENOTHERA has just carried out an... View Article
Naobios signs a Research License Agreement with Valneva on EB66® cell line
Naobios announced the signature of a Research License Agreement with Valneva to assess the EB66® cell line as cell substrate for the evaluation... View Article
Naobios signs a Research License Agreement with Valneva on EB66® cell line
31 May 2025Naobios announced the signature of a Research License Agreement with Valneva to assess the EB66® cell line as cell substrate for the evaluation... View Article
OSE Immunotherapeutics receives €10 Million
This financing will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in therapeutic areas with... View Article
OSE Immunotherapeutics receives €10 Million
31 May 2025This financing will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in therapeutic areas with... View Article
New member | Lyv Healthcare
At the root of Lyv, there is the patient’s reality, from women suffering from endometriosis. Women, who had to go... View Article
New member | Lyv Healthcare
31 May 2025At the root of Lyv, there is the patient’s reality, from women suffering from endometriosis. Women, who had to go... View Article
XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody
Nantes-based biotech XENOTHERA, which develops innovative antibodies in several therapeutic areas, has developed XAV-19, an anti-COVID treatment based on its... View Article
XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody
31 May 2025Nantes-based biotech XENOTHERA, which develops innovative antibodies in several therapeutic areas, has developed XAV-19, an anti-COVID treatment based on its... View Article
New member | HPR Solutions
HPR solutions develops and sales soft mobility solutions called the Urbaner range: 3 electrically assisted tricycles, one of which is... View Article
New member | HPR Solutions
31 May 2025HPR solutions develops and sales soft mobility solutions called the Urbaner range: 3 electrically assisted tricycles, one of which is... View Article
New member | Où suis-je
Où suis-je is an innovative start-up created by Denis TROCH and Dominique MAGUER in March 2022, which offers an application... View Article
New member | Où suis-je
31 May 2025Où suis-je is an innovative start-up created by Denis TROCH and Dominique MAGUER in March 2022, which offers an application... View Article